Enovix Corp
No enriched coverage for $ENVX in the last 7 days.
No SEC Form 4 filings for $ENVX in the last 30 days.
Questel said Enovix selected its Orbit Intelligence software to support Enovix’s patent intelligence and innovation strategy. Enovix, a lithium-ion battery technology company, plans to use Orbit Intelligence for patent search, analytics, and monitoring to aid technology scouting, competitive benchmarking, and R&D decisions, according to the companies.
Enovix shares fell to a new 52-week low, closing at €3.44 and down about 72% over 12 months. JPMorgan downgraded Enovix to Underweight and removed its price target, citing slower smartphone battery ramp at Honor and competitive risks. Enovix reported Q1 revenue of $7.6M and will report Q2 results Aug 12.
TD Cowen cut its Enovix (NASDAQ:ENVX) price target to $5.50 from $7.00 and kept a Hold rating, citing a potential upside of 37.67% versus the stock near $4.00. The article also notes other analyst target changes and that ENVX reported Q1 EPS of -$0.14 on revenue of $7.60M.
Recent ENVX coverage spans financial news, market movers and sector analysis.
The deal is a software/IP-intelligence procurement, likely low near-term financial impact but supportive of Enovix’s R&D and competitive benchmarking workflow.
Street sentiment has turned more bearish on Enovix’s production ramp, increasing downside risk into the next earnings date.
The analyst target cut is a near-term sentiment headwind and may pressure the stock if traders anchor to the new $5.50 level.
The COO appointment is a qualitative execution signal tied to scaling and yield/cost risk, with no new financial guidance or hard operational metrics provided.
The article frames a fresh downside move to new lows, alongside recent earnings and Q2 2026 EPS guidance.
alphai scores every news story that mentions ENVX with an AI model for sentiment and relevance, and aggregates insider trades from Enovix Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Questel said Enovix selected its Orbit Intelligence software to support Enovix’s patent intelligence and innovation strategy. Enovix, a lithium-ion battery technology company, plans to use Orbit Intelligence for patent search, analytics, and monitoring to aid technology scouting, competitive benchmarking, and R&D decisions, according to the companies.
2 min readEnovix shares fell to a new 52-week low, closing at €3.44 and down about 72% over 12 months. JPMorgan downgraded Enovix to Underweight and removed its price target, citing slower smartphone battery ramp at Honor and competitive risks. Enovix reported Q1 revenue of $7.6M and will report Q2 results Aug 12.
6 min readTD Cowen cut its Enovix (NASDAQ:ENVX) price target to $5.50 from $7.00 and kept a Hold rating, citing a potential upside of 37.67% versus the stock near $4.00. The article also notes other analyst target changes and that ENVX reported Q1 EPS of -$0.14 on revenue of $7.60M.
3 min readEnovix (ENVX) said Dr. Michael Vyvoda, a former Apple Product Operations Director, joined as COO on July 29, 2026, overseeing global manufacturing, supply chain and operations engineering across Malaysia, Korea and India. The move targets execution risk as Enovix scales battery production, including its MX 1 defense/drone platform. Enovix projects $586.8M revenue and $36.8M earnings by 2029.
3 min readEnovix (NASDAQ:ENVX) hit a new 52-week low on Thursday, trading as low as $4.42 and last at $4.4350 versus a prior close of $4.68. The article cites analyst target cuts and mixed ratings. It also reports Q1 results: EPS -$0.14 vs -$0.15 consensus, revenue $7.60M vs $6.95M, and Q2 2026 guidance of -0.170 to -0.130.
4 min readOppenheimer highlighted Physical AI “pick and shovel” stocks, citing progress in autonomy, lidar, and battery density. Picks include Tesla, Aeva Technologies, Ouster, Amprius Technologies, Electrovaya, Enovix, and Aurora Innovation. The article cites Tesla Q2 deliveries of 480,100 units and analyst price target increases to $400 and $500, plus Ouster’s PT to $57 and Ouster/Aeva/Amprius/Electrovaya deal and offering updates.
7 min readU.S. index futures were mixed as investors weighed U.S.-Iran tensions and a rebound in semiconductors. Enovix rose 17% after naming former Apple executive Michael Vyvoda COO. Forte Biosciences gained 12% on positive Phase 1b results for FB102 in vitiligo. Rackspace Technology added 8% on a partnership with Palantir. PepsiCo fell 1.8% after mixed Q2 results.
6 min readU.S. index futures were mixed as investors weighed U.S.-Iran tensions and a rebound in semiconductors. In premarket movers, Enovix rose 17% after naming former Apple executive Michael Vyvoda COO to oversee manufacturing ramp in Malaysia and South Korea. Forte Biosciences gained 12% on positive Phase 1b FB102 vitiligo results. Rackspace rose 8% on a Palantir partnership. PepsiCo fell 1.8% after mixed Q2 results.
4 min readEnovix (Nasdaq: ENVX) appointed Dr. Michael Vyvoda as Chief Operating Officer effective July 29, 2026. He will lead global manufacturing, supply chain and operations engineering as the company scales high-volume production at facilities in Malaysia and Korea. Enovix reported Q1 2026 revenue of $7.6 million, up 49% YoY, and a Korea product pipeline over $130 million.
2 min readEnovix (NASDAQ:ENVX) shares rose 17.1% premarket after the company named Dr. Michael Vyvoda, a former Apple operations executive, as COO. He will start July 29, 2026 and oversee global manufacturing, supply chain and operations. Enovix reported Q1 2026 revenue of $7.6M, up 49% YoY, and said production is underway for smart eyewear batteries.
4 min read
